These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11199217)

  • 1. Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography.
    Tata PN; Fu CH; Bramer SL
    J Pharm Biomed Anal; 2001 Jan; 24(3):381-9. PubMed ID: 11199217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatography.
    Fu CJ; Tata PN; Okada K; Akiyama H; Bramer SL
    J Chromatogr B Biomed Sci Appl; 1999 May; 728(2):251-62. PubMed ID: 10406210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatography.
    Tata PN; Fu CH; Browder NJ; Chow PC; Bramer SL
    J Pharm Biomed Anal; 1998 Nov; 18(3):441-51. PubMed ID: 10096838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MS.
    Bramer SL; Tata PN; Vengurlekar SS; Brisson JH
    J Pharm Biomed Anal; 2001 Nov; 26(4):637-50. PubMed ID: 11516916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validated high performance liquid chromatographic method for simultaneous determination of rosiglitazone, cilostazol, and 3,4-dehydro-cilostazol in rat plasma and its application to pharmacokinetics.
    Varanasi VS; Veeraraghavan S; Potharaju S; Thappali RS; Raghavan R; Vakkalanka VS
    Arzneimittelforschung; 2008; 58(6):288-96. PubMed ID: 18677971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography - tandem mass spectrometry for the simultaneous quantitation of glipizide, cilostazol and its active metabolite 3, 4-dehydro-cilostazol in rat plasma: application for a pharmacokinetic study.
    Satheeshmanikandan TR; Sridhar V; Kanthikiran VV; Swaroopkumar VV; Mukkanti K
    Arzneimittelforschung; 2012 Sep; 62(9):425-32. PubMed ID: 22821721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.
    Shah VR; Srinivas NR; Campbell DA; Mantha S; Duncan G; Schuster A; Whigan DW; Shyu WC
    Biomed Chromatogr; 1996; 10(3):135-8. PubMed ID: 8792865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection.
    del Rosario Brunetto M; Contreras Y; Clavijo S; Torres D; Delgado Y; Ovalles F; Ayala C; Gallignani M; Estela JM; Martin VC
    J Pharm Biomed Anal; 2009 Sep; 50(2):194-9. PubMed ID: 19446420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist, TCV-116, and its metabolites in human serum and urine.
    Lee JW; Naidong W; Johnson T; Dzerk A; Miyabayashi T; Motohashi M
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):287-98. PubMed ID: 8548019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study.
    Varanasi KK; Sridhar V; Potharaju S; Shraddha R; Sivakumar SP; Sabapathi SK; Satheeshmanikandan TR; Kumar VV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):91-8. PubMed ID: 18342586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive and specific high-performance liquid chromatographic assay with ultraviolet detection for the determination of cocaine and its metabolites in rat plasma.
    Pan W; Hedaya MA
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):129-38. PubMed ID: 9448069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique.
    Nadarassan DK; Chrystyn H; Clark BJ; Assi KH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):31-7. PubMed ID: 17126087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Shrivasthava W; Datla PV; Yerramilli A
    Anal Bioanal Chem; 2006 Feb; 384(3):780-90. PubMed ID: 16440196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
    Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
    Müller AC; Kanfer I
    J Pharm Biomed Anal; 2010 Sep; 53(1):113-8. PubMed ID: 20395105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine. I. DuP 532 (L-694,492).
    Chiou RH; Lo MW
    J Chromatogr; 1992 Oct; 581(1):165-70. PubMed ID: 1430003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated stability indicating high performance reverse phase liquid chromatographic method for the determination of cilostazol in bulk drug substance.
    Jadhav AS; Pathare DB; Shingare MS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):173-9. PubMed ID: 17454049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection.
    Malavasi B; Ripamonti M; Rouchouse A; Ascalone V
    J Chromatogr A; 1996 Apr; 729(1-2):323-33. PubMed ID: 9004957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of p-chloronitrobenzene and its metabolites in urine by reversed-phase high-performance liquid chromatography.
    Yoshida T
    J Chromatogr; 1993 Mar; 613(1):79-88. PubMed ID: 8458905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
    Furtek CI; Lo MW
    J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.